Prosecution Insights
Last updated: August 18, 2026

Examiner: PETERS, ALEC JON

Tech Center 1600 • Art Units: 1641 1643 1645 1653 1671

This examiner grants 68% of resolved cases

Performance Statistics

67.5%
Allow Rate
+7.5% vs TC avg
91
Total Applications
+56.0%
Interview Lift
1356
Avg Prosecution Days
Based on 40 resolved cases, 2023–2026

Rejection Statute Breakdown

1.7%
§101 Eligibility
13.1%
§102 Novelty
26.8%
§103 Obviousness
31.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18553391 GUCY2C BINDING POLYPEPTIDE AND USES THEREOF Non-Final OA LG CHEM, LTD.
17639794 PROTEINS COMPRISING T-CELL RECEPTOR CONSTANT DOMAINS Non-Final OA The University of North Carolina at Chapel Hill
18252285 NPC1 MONOBODIES AND MONOBODY CONJUGATES THEREOF Non-Final OA NEW YORK UNIVERSITY
18015506 CD22 BINDING MOLECULES AND USES THEREOF Non-Final OA Legend Biotech USA Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month